📊 EDAP Key Takeaways
Is EDAP a Good Investment? Thesis Analysis
Unable to conduct fundamental analysis due to unavailable financial data. All critical income statement, balance sheet, cash flow, and profitability metrics are missing, making it impossible to assess financial health, profitability trends, or growth quality.
Why Buy EDAP? Key Strengths
- No strengths identified
EDAP Investment Risks to Consider
- Complete absence of financial data in SEC filings
- No revenue, earnings, or cash flow information available
- Inability to assess liquidity, solvency, or operational performance
Key Metrics to Watch
- Revenue and gross profit trends
- Operating cash flow and free cash flow generation
- Balance sheet strength and debt levels
EDAP Financial Metrics
💡 AI Analyst Insight
The current ratio below 1.0x warrants monitoring of short-term liquidity.
EDAP Profitability Ratios
EDAP vs Healthcare Sector
How EDAP TMS SA compares to Healthcare sector averages
Sector benchmarks are approximate industry averages. Actual sector performance may vary.
Is EDAP Overvalued or Undervalued?
Based on fundamental analysis, EDAP TMS SA has mixed fundamental signals relative to the Healthcare sector in 2026.
Note: This is a fundamental analysis based on SEC filings. For P/E ratio, price targets, and market-based valuation, consult financial data providers. This is not investment advice.
EDAP Balance Sheet & Liquidity
EDAP Growth Metrics (YoY)
EDAP SEC 10-K & 10-Q Filing Analysis
Access official SEC EDGAR filings for EDAP TMS SA (CIK: 0001041934)
📋 Recent SEC Filings
❓ Frequently Asked Questions about EDAP
What is the AI rating for EDAP?
EDAP TMS SA (EDAP) has an AI rating of HOLD with 5% confidence, based on fundamental analysis of SEC EDGAR filings.
What are EDAP's key strengths?
Claude: .
What are the risks of investing in EDAP?
Claude: Complete absence of financial data in SEC filings. No revenue, earnings, or cash flow information available.
What is EDAP's revenue and growth?
EDAP TMS SA reported revenue of N/A.
Does EDAP pay dividends?
EDAP TMS SA does not currently pay dividends.
Where can I find EDAP SEC filings?
Official SEC filings for EDAP TMS SA (CIK: 0001041934) including 10-K, 10-Q, and 8-K reports are available on SEC EDGAR.
What is EDAP's EPS?
EDAP TMS SA has a diluted EPS of $0.00.
How is the AI analysis conducted?
Two independent AI systems — Claude (Anthropic) and ChatGPT (OpenAI) — analyze SEC EDGAR filings including 10-K annual reports and 10-Q quarterly reports. Each AI evaluates financial health, profitability ratios, balance sheet strength, and growth metrics. The combined rating reflects both perspectives for balanced insights.
Is EDAP a good stock to buy right now?
Based on our AI fundamental analysis in March 2026, EDAP TMS SA has a HOLD rating with 5% confidence. Review the strengths and risks sections above before making a decision. This is not investment advice.
Is EDAP stock overvalued or undervalued?
Valuation metrics for EDAP: ROE of N/A (sector avg: 15%), net margin of N/A (sector avg: 12%). Compare these metrics with sector averages to assess valuation.
Should I buy EDAP stock in 2026?
Our dual AI analysis gives EDAP TMS SA a combined HOLD rating for 2026. Revenue is data pending, with profitability at or below sector average. Always conduct your own research.
What is EDAP's free cash flow?
EDAP TMS SA's operating cash flow is N/A, with capital expenditures of N/A.
How does EDAP compare to other Healthcare stocks?
Vs Healthcare sector averages: Net margin N/A (avg: 12%), ROE N/A (avg: 15%), current ratio N/A (avg: 2).